Michael Witzeman - Chemed Corp Principal Accounting Officer, Controller
| CHE Stock | USD 591.27 9.53 1.59% |
Executive
Mr. Michael D. Witzeman is Principal Accounting Officer, Controller of the Company since 2020.
| Age | 49 |
| Tenure | 5 years |
| Professional Marks | CPA |
| Address | 255 East Fifth Street, Cincinnati, OH, United States, 45202-4726 |
| Phone | 513 762 6690 |
| Web | https://www.chemed.com |
Michael Witzeman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Witzeman against Chemed Corp stock is an integral part of due diligence when investing in Chemed Corp. Michael Witzeman insider activity provides valuable insight into whether Chemed Corp is net buyers or sellers over its current business cycle. Note, Chemed Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Chemed Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Witzeman 2 days ago Disposition of 323 shares by Michael Witzeman of Chemed Corp subject to Rule 16b-3 | ||
Michael Witzeman over six months ago Disposition of 2685 shares by Michael Witzeman of Chemed Corp at 582.95 subject to Rule 16b-3 | ||
Michael Witzeman over a year ago Acquisition by Michael Witzeman of 942 shares of Chemed Corp subject to Rule 16b-3 | ||
Michael Witzeman over a year ago Exercise or conversion by Michael Witzeman of 3300 shares of Chemed Corp subject to Rule 16b-3 |
Chemed Corp Management Efficiency
The company has Return on Asset of 0.1373 % which means that on every $100 spent on assets, it made $0.1373 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2712 %, implying that it generated $0.2712 on every 100 dollars invested. Chemed Corp's management efficiency ratios could be used to measure how well Chemed Corp manages its routine affairs as well as how well it operates its assets and liabilities. At present, Chemed Corp's Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 8.00, whereas Return On Capital Employed is forecasted to decline to 0.14. At present, Chemed Corp's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 196.1 M, whereas Total Current Assets are forecasted to decline to about 198.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Patrick Esq | Healthcare Services Group | 50 | |
| Jason Steik | Pennant Group | N/A | |
| Varun Gadhok | Surgery Partners | N/A | |
| Benjamin Adams | InnovAge Holding Corp | 61 | |
| Cara Babachicos | InnovAge Holding Corp | N/A | |
| FACP MD | InnovAge Holding Corp | 57 | |
| Dustin Lee | InnovAge Holding Corp | N/A | |
| Elissa Charbonneau | Encompass Health Corp | 64 | |
| Andrew Lynch | Acadia Healthcare | N/A | |
| Brett Bearfield | Acadia Healthcare | N/A | |
| Jim Clark | Universal Health Services | N/A | |
| RN BSN | Enhabit | 67 | |
| Roberton Stevenson | Addus HomeCare | 44 | |
| Shelly Eckenroth | Select Medical Holdings | N/A | |
| Thomas Day | Universal Health Services | N/A | |
| Cliff Blessing | Addus HomeCare | 44 | |
| Matt Huray | InnovAge Holding Corp | N/A | |
| Kirk Cheney | Pennant Group | N/A | |
| Langham MBA | Enhabit | 47 | |
| Victor Radina | Universal Health Services | N/A | |
| Roxanne Womack | Surgery Partners | N/A | |
Management Performance
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.14 |
Chemed Corp Leadership Team
Elected by the shareholders, the Chemed Corp's board of directors comprises two types of representatives: Chemed Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemed. The board's role is to monitor Chemed Corp's management team and ensure that shareholders' interests are well served. Chemed Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemed Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Naomi Dallob, Vice President and the Secretary and Chief Legal Officer | ||
| Nathan McNamara, VP Officer | ||
| David Williams, Chief Financial Officer, Executive Vice President | ||
| Andrea Lindell, Independent Director | ||
| George Walsh, Independent Chairman of the Board | ||
| Thomas Rice, Independent Director | ||
| Joel Gemunder, Independent Director | ||
| Sherri Warner, Director Relations | ||
| Patrick Grace, Independent Director | ||
| Frank Wood, Independent Director | ||
| Thomas Hutton, VP Director | ||
| Nicholas Westfall, Executive Vice President | ||
| Christopher Heaney, Independent Director | ||
| Kevin McNamara, President, Chief Executive Officer, Director | ||
| Spencer Lee, Executive Vice President | ||
| Ron DeLyons, Independent Director | ||
| Thomas JD, VP Director | ||
| Donald Saunders, Independent Director | ||
| Michael Witzeman, Principal Accounting Officer, Controller | ||
| Lisa Reinhard, Chief VP | ||
| Brian Judkins, Vice President Chief Legal Officer, Secretary | ||
| Walter Krebs, Independent Director | ||
| Brian JD, Secretary VP |
Chemed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemed Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 8.76 B | ||||
| Shares Outstanding | 14.98 M | ||||
| Shares Owned By Insiders | 2.63 % | ||||
| Shares Owned By Institutions | 94.94 % | ||||
| Number Of Shares Shorted | 313.58 K | ||||
| Price To Earning | 25.42 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Chemed Corp is a strong investment it is important to analyze Chemed Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Chemed Corp's future performance. For an informed investment choice regarding Chemed Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.02 | Dividend Share 1.8 | Earnings Share 19.89 | Revenue Per Share | Quarterly Revenue Growth 0.092 |
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.